Table 1.

Inclusion and exclusion criteria

Inclusion	Exclusion
Papers exploring patients’ and public understanding of PM in relation to cancer treatment. Papers that look at patient or public understanding of PGx testing to inform cancer treatment. At least one group of participants are members of the public or patients and their results are disaggregated.	Papers only looking at patients’ or public understanding of predictive genetic tests for cancer risk genes. Papers reporting solely on clinical outcomes of personalised cancer treatments. Papers that focus on the understanding of personalised treatments used in paediatric oncology. Studies that are reviews, conference abstracts, letters or editorials. Studies not reported in English.